Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07721844

Screening Questionnaires and Musculoskeletal Ultrasound for Early Detection of Spondyloarthritis in IBD Patients

This study aims to evaluate the screening performance of the DETAIL and IBIS-Q questionnaires followed by musculoskeletal ultrasound (MSUS) for the early detection of spondyloarthritis in patients previously diagnosed with Inflammatory Bowel Disease (IBD).

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Inflamatory Bowel Disease Arthritis Bone Diseases Joint Diseases Musculoskeletal Diseases Spinal Diseases Spondylarthritis Spondylitis

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Assiut University Hospital

Asyut, Asyut Governorate, 71515, Egypt

Location contact

Shaimaa Salah Abdelaziz, MBBCH

CONTACT

[email protected]

01093098451

About this study

Inflammatory bowel disease (IBD) is frequently associated with extraintestinal manifestations, with spondyloarthritis (SpA) being the most common. Early detection is crucial to prevent structural damage. This prospective study will screen consecutive adult patients with IBD using the DETAIL and IBIS-Q questionnaires. Patients will then undergo a comprehensive clinical and musculoskeletal ultrasound (MSUS) assessment to evaluate the incremental diagnostic value of ultrasound in detecting early and subclinical SpA.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Adult Aged 18 years old or more Confirmed diagnosis of IBD (by established clinical, endoscopic, and histopathological criteria).

Patient provides informed written consent to participate

Exclusion criteria

Known, pre-existing diagnosis of Spondyloarthritis or any other concomitant systemic autoimmune rheumatic disease.

Severe secondary osteoarthritis or major joint trauma/surgery mimicking SpA. Cognitive impairment or communication barriers preventing comprehension or completion of questionnaires

Treatment and study plan

DETAIL .IBIS_Q . MSUS

Diagnostic Test

All patients will be screened using the DETAIL and IBIS-Q questionnaires, followed by a comprehensive musculoskeletal ultrasound (MSUS) assessment.

Primary outcomes

  1. Prevalence of undiagnosed spondyloarthritis

    Time frame: At the time of clinical evaluation (up to 12 months)

    The percentage of patients with inflammatory bowel disease (IBD) who are newly diagnosed with spondyloarthritis based on DETAIL and IBIS-Q questionnaires followed by musculoskeletal ultrasound (MSUS).

Study contacts

Contact information is provided by the study sponsor or research team.

Shaimaa Salah Abdelaziz, mbbch

CONTACT

[email protected]

01093098451

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

Incremental Value of Musculoskeletal Ultrasound After DETAIL and IBIS-Q Screening for Early Detection of IBD-associated Spondyloarthritis.

Acronym: IBD-MSUS

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Jul 23, 2026
Registry last updated
Jul 23, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.